Breast Cancer Research

official impact factor 5.79

Highly Access Review

New targets for therapy in breast cancer: Mammalian target of rapamycin (mTOR) antagonists

Hetty Carraway* and Manuel Hidalgo

Breast Cancer Res 2004, 6:219-224 doi:10.1186/bcr927

No comments have yet been made on this article.

Post a comment